Aceto’s Rising Pharmaceuticals launches generic Zomig

PORT WASHINGTON, N.Y. — Aceto subsidiary Rising Pharmaceuticals announced Tuesday the planned launch of its generic of Zomig (zolmitriptan) tablets. The drug is indicated to treat migraines with or without an aura in adults. 

 

Rising’s tablets will be available in 2.5- and 5-mg dosage strengths.The product had annual sales of $49 million for the 12 months ended Nov. 30, 2015.